Начало・Списък с акции・Tandem Diabetes Care Inc

Tandem Diabetes Care Inc

Затворен

СекторЗдравеопазване

22.7 -1.52

Купи Продай

Преглед

Промяна на цената на акция

24 ч

Текуща

Минимум

22.35

Максимум

22.78

Ключови измерители
By Trading Economics
Приходи	-775K -21M
Продажби	7.3M 255M
EPS	-0.31
Марж на печалбата	-8.316
Служители	2,500
EBITDA	4.5M -9.2M

Препоръки
By TipRanks
Препоръки	Купи
12-месечна прогноза	+16.64% upside

Дивиденти
By Acuity
Следващи печалби	5.11.2026 г.

Пазарни показатели
By TradingEconomics
Пазарна капитализация	209M 1.6B
Предишно отваряне	24.22
Предишно затваряне	22.7

Настроения в новините

By Acuity

50%

142 / 340 Класиране в Healthcare

Tandem Diabetes Care Inc Графика

Миналото представяне не гарантира бъдещи резултати.

Свързани новини

14.08.2026 г., 20:06 ч. UTC

Tandem Diabetes Care shares are lower today amid economic concerns following a disappointing U.S. retail sales report for July. The stock remains above its 20-day moving average.

13.08.2026 г., 19:16 ч. UTC

Tandem Diabetes Care shares are trading lower today, despite broader market support and an early high. Initial jobless claims rose, indicating potential labor market softening.

12.08.2026 г., 19:41 ч. UTC

News

Tandem Diabetes Care reported a narrower second-quarter loss of 31 cents per share, with revenues of $254.6 million, as shares rise since Tuesday.

11.08.2026 г., 19:46 ч. UTC

News

Tandem Diabetes Care reported improved second-quarter results, including a narrower loss and increased revenue, supporting shares' advance during Tuesday's session.

10.08.2026 г., 19:36 ч. UTC

News

Tandem Diabetes Care reported second-quarter revenue of $254.6 million and reaffirmed its full-year guidance of $1.08 billion, supporting a higher share price today.

7.08.2026 г., 20:02 ч. UTC

News

Tandem Diabetes Care shares rose after Q2 sales of $254.6 million and adjusted EBITDA of $6.4 million exceeded forecasts, despite RBC lowering its price target to $26.

6.08.2026 г., 23:02 ч. UTC

News

Tandem Diabetes Care reported Q2 sales of $254.6 million and reaffirmed revenue guidance, with shares trading higher in after-market hours.

5.08.2026 г., 19:56 ч. UTC

News

Tandem Diabetes Care Inc's shares are declining amid negative sentiment in the insulin sector following Insulet Corp's lowered revenue growth forecast.

4.08.2026 г., 19:46 ч. UTC

Tandem Diabetes Care Inc shares are lower today, influenced by declines in the Health Care Equipment sub-sector. Earlier, the stock reached a session high before pulling back.

31.07.2026 г., 19:51 ч. UTC

Tandem Diabetes Care Inc is advancing today, benefiting from positive market sentiment driven by technology stocks, despite pulling back from earlier session highs.

30.07.2026 г., 17:11 ч. UTC

Tandem Diabetes Care shares are lower today as the Health Care Equipment sub-sector declines. The asset remains above its 20-day moving average.

29.07.2026 г., 18:15 ч. UTC

Tandem Diabetes Care Inc. shares are higher, driven by significant gains in Health Care Equipment stocks, despite a recent trend of daily price increases.

27.07.2026 г., 19:21 ч. UTC

Tandem Diabetes Care Inc. shares are lower, reflecting broader market trends amid declining oil prices and easing geopolitical tensions ahead of the Federal Reserve meeting.

24.07.2026 г., 14:02 ч. UTC

Tandem Diabetes Care Inc shares are lower today, with no specific news identified. Broader market concerns follow a significant sell-off on Thursday.

21.07.2026 г., 19:06 ч. UTC

Tandem Diabetes Care is lower today, driven by declines in the Health Care Equipment sub-sector. The asset has fallen steadily after an early high.

20.07.2026 г., 17:26 ч. UTC

Tandem Diabetes Care Inc shares are higher today, recovering from an early dip. The stock has gained significantly since last month’s close.

Сравнение с други в отрасъла

Ценова промяна

Tandem Diabetes Care Inc Прогноза

Ценова цел

By TipRanks

16.64% нагоре

12-месечна прогноза

Среден 26.5 USD 16.64%

Висок 50 USD

Нисък 15.5 USD

Според 15 анализатори от Wall Street, предложили 12-месечна ценова цел за Tandem Diabetes Care Inc през последните три месеца.

Консенсусна оценка

By TipRanks

Купи

15 ratings

Купи

Задържане

Продай

Според 15 анализатори, дали борсови рейтинги на Tandem Diabetes Care Inc през последните 3 месеца.

Настроение

By Acuity

142 / 340 Класиране в Здравеопазване

Финанси

Продажбени и админисративни разходи

Оперативни разходи

Печалба преди облагане с данъци

Продажби

Разходи за продажби

Брутна печалба от продажби

Разходи за лихви по дълг

EBITDA

Оперативна печалба

Относно Tandem Diabetes Care Inc

Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform for managing insulin delivery and display continuous glucose monitoring sensor information directly on the pump home screen; and Tandem Mobi insulin pump, an automated insulin delivery system. It also sells single-use products, including cartridges for storing and delivering insulin, and infusion sets that connect the insulin pump to the user's body. In addition, the company offers Tandem Device Updater used to update the pump software from a personal computer; Tandem Source, a web-based data management platform, which provides a visual way to display diabetes therapy management data from the pumps, integrated CGMs, and supported blood glucose meters; and Sugarmate, a mobile app used to help people visualize diabetes therapy data. It has collaboration agreement with the University of Virginia Center for Diabetes Technology for research and development of fully automated closed-loop insulin delivery systems. The company was formerly known as Phluid Inc. and changed its name to Tandem Diabetes Care, Inc. in January 2008. Tandem Diabetes Care, Inc. was incorporated in 2006 and is headquartered in San Diego, California.